Bulletin
Investor Alert

Dare Bioscience Inc.

NAS: DARE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 1, 2022, 7:09 p.m.

/zigman2/quotes/203460984/composite

$

1.18

Change

-0.01 -0.84%

Volume

Volume 1,901

Quotes are delayed by 20 min

/zigman2/quotes/203460984/composite

Previous close

$ 1.23

$ 1.19

Change

-0.04 -3.25%

Day low

Day high

$1.18

$1.24

Open

52 week low

52 week high

$0.92

$2.51

Open

Annual Financials for Dare Bioscience Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A -2,44011,13743,22726,413
COGS excluding D&A -----
Depreciation & Amortization Expense -2,44011,13743,22726,413
Depreciation -2,44011,13743,22726,413
Amortization of Intangibles -----
Gross Income -(2,440)(11,137)(43,227)(26,413)
20172018201920202021 5-year trend
SG&A Expense 3.69M11.69M14.33M27.36M39.04M
Research & Development 984,7496.41M8.55M20.77M30.62M
Other SG&A 2.7M5.28M5.79M6.59M-
Other Operating Expense -----
Unusual Expense 7.49M5.19M--(369,887)
EBIT after Unusual Expense (11.18M)(16.88M)--(38.7M)
Non Operating Income/Expense -143,50081,0501,5102,520
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense 322,629----
Gross Interest Expense 322,629----
Interest Capitalized -----
Pretax Income (11.5M)(16.74M)(14.26M)(27.4M)(38.7M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (11.5M)(16.74M)(14.26M)(27.4M)(38.7M)
Minority Interest Expense -----
Net Income (11.5M)(16.74M)(14.26M)(27.4M)(38.7M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (11.5M)(16.74M)(14.26M)(27.4M)(38.7M)
Preferred Dividends --789,5946,863-
Net Income Available to Common (11.5M)(16.74M)(15.05M)(27.41M)(38.7M)
EPS (Basic) (3.56)(1.56)(0.97)(0.91)(0.63)
Basic Shares Outstanding 3.23M10.73M15.58M30.09M61.15M
EPS (Diluted) (3.56)(1.56)(0.97)(0.91)(0.63)
Diluted Shares Outstanding 3.23M10.73M15.58M30.09M61.15M
EBITDA (3.69M)(11.69M)(14.33M)(27.36M)(39.04M)
Link to MarketWatch's Slice.